Fatty Liver Disease Linked to 69% Higher Risk of Major Cardiac Events

A recent study published in Clinical Gastroenterology and Hepatology highlights a critical, often overlooked connection between liver health and cardiovascular disease. Researchers analyzing data from over 3,600 patients found that individuals with fatty liver disease—specifically hepatic steatosis—exhibit a significantly higher burden of noncalcified, high-risk arterial plaque. Unlike stable calcified plaque, this softer, inflamed variety is more prone to rupture, directly increasing the likelihood of heart attacks and other major cardiac events.

The study revealed that even after accounting for traditional risk factors such as obesity, hypertension, and diabetes, the presence of fatty liver disease independently correlates with a 69% increased risk of severe cardiovascular complications. This suggests that the liver may serve as a vital diagnostic window into systemic metabolic health, acting as an early warning system for dangerous changes occurring within the cardiovascular architecture.

This research underscores the existence of a "liver-heart axis," where metabolic dysfunction manifests simultaneously across multiple organ systems. Given that fatty liver disease is often asymptomatic and currently affects over a billion people globally, these findings emphasize the need for clinicians to look beyond standard cholesterol and blood pressure metrics. Recognizing fatty liver as a precursor to cardiovascular damage could allow for earlier intervention, potentially mitigating long-term risks through targeted lifestyle modifications and improved metabolic management.